Additional Proxy Soliciting Materials (definitive) (defa14a)
March 29 2021 - 2:47PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by
the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the
appropriate box:
[_]
|
Preliminary Proxy Statement
|
[_]
|
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by
Rule 14a-6(e)(2))
|
[_]
|
Definitive Proxy Statement
|
[X]
|
Definitive Additional Materials
|
[_]
|
Soliciting Material Pursuant to Section
240.14a-12
|
Pfizer
Inc.
|
(Name of Registrant as Specified In Its Charter)
|
|
|
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)
|
Payment of
Filing Fee (Check the appropriate box):
[X]
|
No fee required.
|
|
[_]
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
|
|
1)
|
Title of each class of securities to which transaction
applies:
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
5)
|
Total fee paid:
|
|
|
[_]
|
Fee paid previously with preliminary materials:
|
|
|
[_]
|
Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the form or schedule and the date of its
filing.
|
|
|
|
1)
|
Amount previously paid:
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
3)
|
Filing Party:
|
|
|
|
4)
|
Date
Filed:
|
|
|
|
|
Margaret M. Madden
235 East 42nd Street, New York, NY 10017
YOUR VOTE IS IMPORTANT TO US - PLEASE
VOTE YOUR SHARES TODAY
Dear Fellow Pfizer Shareholder:
On April 22, 2021, Pfizer will hold its
Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials
and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy.
For the reasons set forth in the 2021 Proxy
Statement, the Board of Directors recommends that you vote:
•
|
“FOR” each director nominee;
|
•
|
“FOR” the ratification of the selection of KPMG LLP as the independent registered public accounting firm for 2021;
|
•
|
“FOR” the 2021 advisory approval of executive compensation; and
|
•
|
“AGAINST” the three shareholder proposals.
|
For your convenience, a duplicate proxy/voting
instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. In the event that multiple
proxies/voting instruction cards are received from you, the one with the latest date will be counted.
In response to continued public health concerns
related to the COVID-19 pandemic, and to support the health and well-being of our shareholders and other meeting participants,
the 2021 Annual Meeting will be held in a virtual meeting format only. Please view our proxy statement for additional details on
how you can participate.
Your vote is important and valued. I encourage
you to vote in advance of the Annual Meeting by one of the methods described in the proxy materials and duplicate proxy/voting
instruction card. Please act today to be sure your shares are voted.
Sincerely,
Margaret M. Madden
Senior Vice President and Corporate Secretary, Chief Governance
Counsel
Breakthroughs that change patients’ lives
|
pfizer.com
|
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024